Frank Stokes serves as the Chief Financial Officer at Castle Biosciences, Inc., a leading diagnostics company focused on improving the management of cancer and other diseases through innovative testing solutions. With a robust background in financial management and strategic planning, Stokes has been instrumental in guiding Castle Biosciences through its growth and development phases. He joined the company in 2017 and has since played a pivotal role in its financial operations, including overseeing the company's successful initial public offering (IPO) in 2019. Prior to his role at Castle Biosciences, Stokes held various high-level financial positions at several notable healthcare and life sciences companies. He spent over a decade at Luminex Corporation, where he progressed from Director of Finance to Vice President of Finance, gaining extensive experience in financial strategy and corporate development. Stokes also worked at the global healthcare company, Cardinal Health, where he honed his skills in financial planning and analysis. His expertise in navigating complex financial landscapes and his strategic foresight have been key to Castle Biosciences' sustained growth and market positioning. At Castle Biosciences, Stokes is responsible for managing the company's financial strategy, which includes budgeting, forecasting, and investor relations. His leadership has been crucial in securing funding and resources to support the company's research and development efforts, ultimately aiding in the expansion of their diagnostic product offerings. Under his stewardship, Castle Biosciences has not only solidified its financial standing but has also continued to innovate and expand its reach in the diagnostics industry, improving patient outcomes across various diseases.